Medical Marijuana, Inc. Reports $7.8 Million in Net Revenue in 2022 First Quarter Financial and Operational Results
SAN DIEGO, CA, May 19, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands, and supply chain, announced today its financial results for the quarter ending March 31, 2022, and provided an overview of recent operational highlights. First Quarter 2022 Financial and Operational Highlights Generated $7.8 million in net revenue in the first quarter of 2022, a 24% increase when compared to the previous quarter; Net Cash Provided by Operating Activities was $.6 million, a substantial increase from the previous quarter; Gross profit for the period ending March 31, 2022, was $5.7 million with gross margins of 73%; Cash at the end of the period ending March 31, 2022, was $5 million; Medical Marijuana, Inc. international operations continued to experience revenue mile...